+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Synthetic Hormones Market by Hormone Class, Application, Technology, End User - Global Forecast to 2030- Product Image
Synthetic Hormones Market by Hormone Class, Application, Technology, End User - Global Forecast to 2030- Product Image
Sale

Synthetic Hormones Market by Hormone Class, Application, Technology, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533197
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The synthetic hormones market is evolving rapidly owing to demographic changes, shifting patient needs, and innovation in delivery technologies. For organizations navigating pharmaceutical value chains, staying ahead demands both strategic foresight and a firm understanding of regulatory and operational shifts. Decision-makers require actionable intelligence to align product portfolios with current and emerging demand.

Market Snapshot: Synthetic Hormones Market

The Synthetic Hormones Market grew from USD 1.02 billion in 2024 to USD 1.17 billion in 2025. It is expected to continue growing at a CAGR of 14.52%, reaching USD 2.31 billion by 2030. This growth reflects increasing prevalence of hormone-related conditions and ongoing investments in advanced therapeutic options worldwide. Regulatory bodies are raising quality standards and healthcare providers are incorporating more sophisticated treatment protocols, reinforcing the importance of innovation and compliance for market players.

Scope & Segmentation

  • Hormone Classes: Estrogen, Insulin, Thyroid
  • Applications: Contraception (Combined Oral Contraceptives, Progestin-Only Contraceptives), Diabetes, Growth Hormone Deficiency (Adult and Pediatric GHD), Menopausal Symptoms (Hot Flashes, Osteoporosis, Vaginal Atrophy), Thyroid Disorders (Hyperthyroidism, Hypothyroidism)
  • Technologies: Chemical Synthesis (Liquid-Phase, Solid-Phase), Recombinant DNA (Bacterial, Mammalian Cell, Yeast Expression Systems)
  • End Users: Clinics (General Practice, Specialty), Homecare Settings (Nursing Services, Self-Administration), Hospitals (Private, Public), Online Pharmacies (Over-the-Counter, Prescription-Based), Retail Pharmacies (Chain, Independent)
  • Regions: Americas (United States [California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio], Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Companies: Novo Nordisk A/S, Sanofi S.A., Eli Lilly and Company, Pfizer Inc., Ferring Pharmaceuticals S.A., Teva Pharmaceutical Industries Ltd., Bayer AG, Novartis AG, Merck & Co., Inc., AbbVie Inc.

Key Takeaways for Senior Leaders

  • Continuous research in hormone analogues and biosimilars is intensifying, driven by the growing burden of endocrine disorders globally.
  • Adoption of advanced manufacturing practices, including recombinant DNA and continuous processing, is streamlining production and enabling product portfolio diversification.
  • Patient-centric advances such as long-acting injectables, transdermal systems, and integration of digital health tools are setting new standards in treatment adherence and clinical outcomes.
  • Collaborations between pharmaceutical manufacturers, payers, and healthcare providers are increasingly focused on value-based care and outcome-driven reimbursement models.
  • Local manufacturing, especially in emerging markets, supports cost optimization and ensures timely supply, enhancing resilience against external shocks.
  • Strategic alliances with contract development and manufacturing organizations are pivotal for market access, especially under changing regulatory and tariff conditions.

Tariff Impact: U.S. 2025 Considerations

The introduction of cumulative tariffs in the United States in 2025 has increased production costs for intermediates and active pharmaceutical ingredients. This has created downstream pressure on procurement, pricing, and supply chain management. Manufacturers are increasing supply diversification and pursuing onshore production to reduce exposure to future tariff-related disruptions, making operational flexibility a priority.

Methodology & Data Sources

This analysis integrates multiple data streams, including in-depth interviews with endocrinologists, formulators, regulatory specialists, and supply chain executives. Secondary research encompassed regulatory filings, peer-reviewed journals, company presentations, and industry databases. Expert panels validated findings to ensure credibility, and structured editorial reviews maintained clarity throughout the report.

Why This Report Matters

  • Enables informed portfolio planning and market-entry strategies through a comprehensive review of competitive, regulatory, and technological trends.
  • Supports operational decisions by detailing segment-specific growth opportunities and regional market nuances critical for expansion and risk management.
  • Equips leadership teams with actionable intelligence for engaging payers, regulators, and distribution partners in key markets.

Conclusion

The synthetic hormones market is in transition, shaped by regulatory shifts, new technologies, and regional complexity. Senior decision-makers using these insights will be better positioned to navigate fast-changing conditions and sustain competitive advantages.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Synthetic Hormones Market, by Hormone Class
8.1. Introduction
8.2. Estrogen
8.3. Insulin
8.4. Thyroid
9. Synthetic Hormones Market, by Application
9.1. Introduction
9.2. Contraception
9.2.1. Combined Oral Contraceptive
9.2.2. Progestin Only Contraceptive
9.3. Diabetes
9.4. Growth Hormone Deficiency
9.4.1. Adult GHD
9.4.2. Pediatric GHD
9.5. Menopausal Symptoms
9.5.1. Hot Flashes
9.5.2. Osteoporosis
9.5.3. Vaginal Atrophy
9.6. Thyroid Disorders
9.6.1. Hyperthyroidism
9.6.2. Hypothyroidism
10. Synthetic Hormones Market, by Technology
10.1. Introduction
10.2. Chemical Synthesis
10.2.1. Liquid-Phase Synthesis
10.2.2. Solid-Phase Synthesis
10.3. Recombinant Dna Technology
10.3.1. Bacterial Expression Systems
10.3.2. Mammalian Cell Expression Systems
10.3.3. Yeast Expression Systems
11. Synthetic Hormones Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. General Practice Clinics
11.2.2. Specialty Clinics
11.3. Homecare Settings
11.3.1. Nursing Service
11.3.2. Self-Administration
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
11.5. Online Pharmacies
11.5.1. Over-The-Counter
11.5.2. Prescription-Based
11.6. Retail Pharmacies
11.6.1. Chain Pharmacies
11.6.2. Independent Pharmacies
12. Americas Synthetic Hormones Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Synthetic Hormones Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Synthetic Hormones Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Novo Nordisk A/S
15.3.2. Sanofi S.A.
15.3.3. Eli Lilly and Company
15.3.4. Pfizer Inc.
15.3.5. Ferring Pharmaceuticals S.A.
15.3.6. Teva Pharmaceutical Industries Ltd.
15.3.7. Bayer AG
15.3.8. Novartis AG
15.3.9. Merck & Co., Inc.
15.3.10. AbbVie Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SYNTHETIC HORMONES MARKET MULTI-CURRENCY
FIGURE 2. SYNTHETIC HORMONES MARKET MULTI-LANGUAGE
FIGURE 3. SYNTHETIC HORMONES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SYNTHETIC HORMONES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SYNTHETIC HORMONES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SYNTHETIC HORMONES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SYNTHETIC HORMONES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SYNTHETIC HORMONES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN ONLY CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ADULT GHD, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PEDIATRIC GHD, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOT FLASHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY VAGINAL ATROPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HYPERTHYROIDISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HYPOTHYROIDISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY LIQUID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GENERAL PRACTICE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY NURSING SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SELF-ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 92. CANADA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 93. CANADA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. CANADA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 95. CANADA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 96. CANADA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 97. CANADA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 98. CANADA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. CANADA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 100. CANADA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. CANADA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. CANADA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 103. CANADA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 104. CANADA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 105. CANADA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 106. CANADA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 107. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 108. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 110. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 111. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 121. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 183. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 184. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 186. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 187. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 188. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 189. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 191. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 194. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 195. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 196. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 197. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 198. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 199. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 201. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 202. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 203. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 204. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 206. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 209. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 210. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 212. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 228. ITALY SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 229. ITALY SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. ITALY SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 231. ITALY SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 232. ITALY SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 233. ITALY SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 234. ITALY SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. ITALY SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 236. ITALY SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. ITALY SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. ITALY SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 239. ITALY SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 240. ITALY SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. ITALY SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 242. ITALY SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 243. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 244. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 246. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 247. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 248. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 249. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 251. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 254. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 255. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 256. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 257. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 300. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 303. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 304. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 306. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 307. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 308. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 309. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 310. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 311. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 314. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 315. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 316. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 317. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 318. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 325. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 326. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 327. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 329. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 330. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 331. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 332. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 333. QATAR SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 334. QATAR SYNTHETIC HORMO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Synthetic Hormones market report include:
  • Novo Nordisk A/S
  • Sanofi S.A.
  • Eli Lilly and Company
  • Pfizer Inc.
  • Ferring Pharmaceuticals S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Novartis AG
  • Merck & Co., Inc.
  • AbbVie Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.17 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.31 Billion
Compound Annual Growth Rate14.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Addison's Disease Treatment Market by Treatment Type, Administration Route, End User, Distribution Channel, Age Group - Global Forecast to 2030 - Product Image

Addison's Disease Treatment Market by Treatment Type, Administration Route, End User, Distribution Channel, Age Group - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Synthetic Hormones Market Report 2025 - Product Image

Synthetic Hormones Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Drugs for Hormonal Replacement Therapy Market Report 2025 - Product Image

Drugs for Hormonal Replacement Therapy Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Human Growth Hormone Drugs - Global Strategic Business Report - Product Image

Human Growth Hormone Drugs - Global Strategic Business Report

  • Report
  • 335 Pages
  • Global
From

About the Synthetic Hormone Market

The Synthetic Hormone market is a subset of the Endocrine and Metabolic Disorders Drugs market. Synthetic Hormones are drugs that are designed to mimic the effects of naturally occurring hormones in the body. These drugs are used to treat a variety of endocrine and metabolic disorders, such as diabetes, thyroid disorders, and growth hormone deficiencies. Synthetic Hormones are also used to treat menopausal symptoms, such as hot flashes and night sweats. Synthetic Hormones are typically administered orally, through injections, or through topical creams. The market for Synthetic Hormones is expected to grow in the coming years due to the increasing prevalence of endocrine and metabolic disorders, as well as the aging population. Some companies in the Synthetic Hormone market include Novo Nordisk, Eli Lilly, Merck, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.